Genomic Biomarkers Market Size, Share, Growth Report 2032

Genomic Biomarkers Market

Genomic Biomarkers Market By Indication (Oncology, Diagnostic & Research Laboratories diseases, Neurological diseases, and others) By End User (Hospitals, Diagnostic & Research Laboratories, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032

Category: Pharmaceutical Report Format : PDF Pages: 142 Report Code: ZMR-2550 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 5.29 Billion USD 9.41 Billion 6.62% 2023

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Indication
        • 2.1.1.2. Market Attractiveness Analysis, By End User
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Genomic Biomarkers Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Genomic Biomarkers Market – Indication Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Indication, 2020 & 2028
    • 4.2. Onculogy
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Cardiovascular diseases
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Neurulogical diseases
      • 4.4.1. Market Size and Forecast, By Region (USD Billion)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Others
      • 4.5.1. Market Size and Forecast, By Region (USD Billion)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Genomic Biomarkers Market – End User Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By End User, 2020 & 2028
    • 5.2. Hospitals
      • 5.2.1. Market Size and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Diagnostic & Research Laboratories
      • 5.3.1. Market Size and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Others
      • 5.4.1. Market Size and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.2.2. North America Market Revenue, By Indication, 2016 – 2028
      • 6.2.3. North America Market Revenue, By End User, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Indication, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By End User, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By Indication, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, By End User, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By Indication, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, By End User, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.3.2. Europe Market Revenue, By Indication, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By End User, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By Indication, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, By End User, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By Indication, 2016 – 2028
        • 6.3.6.2. France Market Revenue, By End User, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By Indication, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, By End User, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By Indication, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, By End User, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By Indication, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, By End User, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By Indication, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, By End User, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.4.2. Asia Pacific Market Revenue, By Indication, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By End User, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Indication, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By End User, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Indication, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By End User, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Indication, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By End User, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Indication, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By End User, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Indication, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By End User, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Indication, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By End User, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.5.2. Latin America Market Revenue, By Indication, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By End User, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By Indication, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, By End User, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By Indication, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, By End User, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By Indication, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, By End User, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Indication, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By End User, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By Indication, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, By End User, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By Indication, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, By End User, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Indication, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By End User, 2016 – 2028
  • Chapter No. 7: Genomic Biomarkers Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Indication Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Genomic Biomarkers Market: Company Market Share, 2019
      • 8.1.2. Global Genomic Biomarkers Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 8.1.3. Global Genomic Biomarkers Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Genomic Biomarkers Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. THERMO FISHER SCIENTIFIC
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Roche Diagnostics
    • 9.3. Myriad Genetics
    • 9.4. QIAGEN
    • 9.5. Bio-Rad Laboratories
    • 9.6. US Biomarkers Inc
    • 9.7. Almac Group and Epigenomics
  • Chapter No. 10: Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Indication
FIG NO. 2. Market Attractiveness Analysis, By End User
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Genomic Biomarkers Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Indication, 2020 & 2028 
FIG NO. 7. Global Genomic Biomarkers Market for Oncology, Revenue (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Genomic Biomarkers Market for Oncology, By Country, 2020 & 2028
FIG NO. 9. Global Genomic Biomarkers Market for Cardiovascular diseases, Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Genomic Biomarkers Market for Cardiovascular diseases, By Country, 2020 & 2028
FIG NO. 11. Global Genomic Biomarkers Market for Neurological diseases, Revenue (USD Billion) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Genomic Biomarkers Market for Neurological diseases, By Country, 2020 & 2028
FIG NO. 13. Global Genomic Biomarkers Market for others, Revenue (USD Billion) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Genomic Biomarkers Market for others, By Country, 2020 & 2028
FIG NO. 15. Global Genomic Biomarkers Market for Oncology, Revenue (USD Billion) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Genomic Biomarkers Market for Oncology, By Country, 2020 & 2028
FIG NO. 17. Global Genomic Biomarkers Market for Respiratory, Revenue (USD Billion) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Genomic Biomarkers Market for Respiratory, By Country, 2020 & 2028
FIG NO. 19. Global Genomic Biomarkers Market for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 20. Global Genomic Biomarkers Market Revenue Share, By Region, 2020 & 2028
FIG NO. 21. North America Genomic Biomarkers Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 22. Porter’s Five Forces Analysis for Global Genomic Biomarkers Market
FIG NO. 23. PEST Analysis for Global Genomic Biomarkers Market
FIG NO. 24. Pricing Analysis for Global Genomic Biomarkers Market
FIG NO. 25. Value Chain Analysis for Global Genomic Biomarkers Market
FIG NO. 26. Company Share Analysis, 2019
FIG NO. 27. Radar Determinant Chart, 2019
FIG NO. 28. Company Strategic Developments – Heat Map Analysis
FIG NO. 29. Thermo Fisher Scientific Business Segment Revenue Share, 2020 (%)
FIG NO. 30. Thermo Fisher Scientific Geographical Segment Revenue Share, 2020 (%)
FIG NO. 31. Market Channels 
FIG NO. 32. Marketing Channel Development Trend
FIG NO. 33. Growth in World Gross Product, 2008-2018
FIG NO. 34. Research Methodology – Detailed View
FIG NO. 35. Research Methodology
 


Table Of Tables

List of Tables 

TABLE NO. 1. Global Genomic Biomarkers Market: Snapshot
TABLE NO. 2. Quarterly Genomic Biomarkers Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Genomic Biomarkers Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion) 
TABLE NO. 6. Global Genomic Biomarkers Market for Oncology, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Genomic Biomarkers Market for Cardiovascular diseases, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Genomic Biomarkers Market for Neurological diseases, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9. Global Genomic Biomarkers Market for Others, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10: Global Genomic Biomarkers Market for Hospitals, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11: Global Genomic Biomarkers Market for Diagnostic & Research Laboratories, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12. Global Genomic Biomarkers Market for Others, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 13. Global Genomic Biomarkers Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 14: North America Genomic Biomarkers Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 15. North America Genomic Biomarkers Market Revenue, By Indication, 2016 – 2028 (USD Billion)
TABLE NO. 16: North America Genomic Biomarkers Market Revenue, By End User, 2016 – 2028 (USD Billion)
TABLE NO. 17. U.S. Genomic Biomarkers Market Revenue, By Indication, 2016 – 2028 (USD Billion)
TABLE NO. 18. U.S. Genomic Biomarkers Market Revenue, By End User, 2016 – 2028 (USD Billion)
TABLE NO. 19. Canada Genomic Biomarkers Market Revenue, By Indication, 2016 – 2028 (USD Billion)
TABLE NO. 20. Canada Genomic Biomarkers Market Revenue, By End User, 2016 – 2028 (USD Billion)
TABLE NO. 21. Mexico Genomic Biomarkers Market Revenue, By Indication, 2016 – 2028 (USD Billion)
TABLE NO. 22: Mexico Genomic Biomarkers Market Revenue, By End User, 2016 – 2028 (USD Billion)
TABLE NO. 23 Drivers for the Genomic Biomarkers Market: Impact Analysis 
TABLE NO. 24. Restraints for the Genomic Biomarkers Market: Impact Analysis
TABLE NO. 25. Major Buyers of Genomic Biomarkers   
TABLE NO.26: Distributors/Traders List of Genomic Biomarkers
TABLE NO. 27. Global Genomic Biomarkers Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 28: Global Genomic Biomarkers Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)   
 

Methodology

FrequentlyAsked Questions

The global Genomic Biomarkers Market was valued at US$ 5.29 Billion in 2023.

 

 

The global Genomic Biomarkers Market is expected to reach US$ 9.41 Billion by 2032 at a CAGR of about 6.62% from 2024 to 2032.

Some of the key factors driving the global Genomic Biomarkers Market growth are growing prevalence of life-threatening diseases such as cancer, cardiovascular diseases and neurological disorders across the globe.

North America is anticipated to remain the leading region over the forecast period followed by Europe. Demand for genomic biomarkers was highest in North America especially in the U.S. Asia Pacific is expected to be the highest growing region in genomic biomarkers market during the forecast period. Moreover, the Middle East and Africa and Latin America are also expected to show moderate growth for this market in the years to come.

Some of the major players of global Genomic Biomarkers market Thermo Fisher Scientific, Roche Diagnostics, Myriad Genetics, QIAGEN, Bio-Rad Laboratories, US Biomarkers Inc., Almac Group and Epigenomics AG among others.

Choose License Type

  • zion payment modes

List of Contents

Market InsightsMarket Overview Growth Factors Report ScopeSegment Analysis Preview End User Analysis PreviewRegional PreviewKey Market Players Competitive LandscapeThe global market is segmented as follows:

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed